Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep;12(9):e2738.
doi: 10.1002/brb3.2738. Epub 2022 Aug 8.

Cancer-related stroke: Exploring personalized therapy strategies

Affiliations
Review

Cancer-related stroke: Exploring personalized therapy strategies

Yu-Jie Chen et al. Brain Behav. 2022 Sep.

Abstract

Background: Cancer and ischemic stroke are two common diseases that threaten human health and have become the main causes of death in the world. It is estimated that one-in-ten patients with ischemic stroke have concomitant cancer, and this incidence is expected to increase as improvements in medical technology extends the life expectancy of cancer patients.

Discussion: Cancer-related stroke (CRS) refers to unexplained ischemic stroke in patients with active cancer that cannot be explained by current stroke mechanisms. Available evidence suggests that CRS accounts for 5-10% of embolic stroke of undetermined source (ESUS). Although the incidence of CRS is gradually increasing, its underlying pathogenesis remains unclear. Also, there is no consensus on acute treatment and secondary prevention of stroke.

Conclusion: In this review, we retrospectively analyzed the incidence, mechanisms of CRS, its potential as a new stroke subtype, options for acute treatment, secondary prevention strategies, and disease progression, with the aim of attempting to explore personalized therapy strategies.

Keywords: cancer-related stroke; embolic stroke of undetermined source; hypercoagulability; individualized therapy; pathogenesis; stroke subtype.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
CRS challenges TOAST subtypes
FIGURE 2
FIGURE 2
Possible mechanisms between stroke and tumor. EVs, extracellular vesicles; NET, neutrophil extracellular trap

References

    1. ÃInle, F. N. A. , & Kevane, B. (2020). Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)? Hematology (Amsterdam, Netherlands), American Society of Hematology. Education Program, 2020(1), 201–212. 10.1182/hematology.2020002268 - DOI - PMC - PubMed
    1. Abu Saadeh, F. , Langhe, R. , Galvin, D. M. , O Toole, S. A. , O'donnell, D. M. , Gleeson, N. , & Norris, L. A. (2016). Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy. Thrombosis Research, 139, 135–141. 10.1016/j.thromres.2016.01.027 - DOI - PubMed
    1. Adams, H. P. (2019). Cancer and cerebrovascular disease. Current Neurology and Neuroscience Reports, 19(10), 73. 10.1007/s11910-019-0985-0 - DOI - PubMed
    1. Adams, H. P. , Bendixen, B. H. , Kappelle, L. J. , Biller, J. , Love, B. B. , Gordon, D. L. , & Marsh, E. E. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke; A Journal of Cerebral Circulation, 24(1), 35–41. 10.1161/01.str.24.1.35 - DOI - PubMed
    1. Agnelli, G. , Becattini, C. , Meyer, G. , Muã±Oz, A. , Huisman, M. V. , Connors, J. M. , Cohen, A. , Bauersachs, R. , Brenner, B. , Torbicki, A. , Sueiro, M. R. , Lambert, C. , Gussoni, G. , Campanini, M. , Fontanella, A. , Vescovo, G. , & Verso, M. (2020). Apixaban for the treatment of venous thromboembolism associated with cancer. The New England Journal of Medicine, 382(17), 1599–1607. 10.1056/NEJMoa1915103 - DOI - PubMed

Publication types